Cargando…

The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease

BACKGROUND: The level of lipoprotein-associated phospholipase A2 (LP-PLA2) in serum is independently correlated to coronary artery diseases (CAD). The aim of the study was to determine whether LP-PLA2 activity is positively associated with the seriousness of CAD. METHODS: Amount to 1056 patients sus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hao, Gao, Yang, Wu, Dan, Zhang, Dingguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298745/ https://www.ncbi.nlm.nih.gov/pubmed/32546193 http://dx.doi.org/10.1186/s12872-020-01580-4

Ejemplares similares

The Relationship Between Lipoprotein-Associated Phospholipase-A2 and Coronary Artery Aneurysm in Children With Kawasaki Disease
por: Cheng, Zhenli, et al.
Publicado: (2022)

Relationship between Plasma Lipoprotein-Associated Phospholipase A2 Concentrations and Apolipoprotein in Stable Coronary Artery Disease Patients
por: Ling, Yang, et al.
Publicado: (2020)

Lipoprotein-Associated Phospholipase A2 Activity Predicts Cardiovascular Events in High Risk Coronary Artery Disease Patients
por: Maiolino, Giuseppe, et al.
Publicado: (2012)

Correlation between plasma lipoprotein-associated phospholipase A(2) and peripheral arterial disease
por: LI, SHUAI-BING, et al.
Publicado: (2013)

Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease
por: Mourouzis, Konstantinos, et al.
Publicado: (2021)

Association of Lipoprotein-Associated Phospholipase A(2) with Characteristics of Vulnerable Coronary Atherosclerotic Plaques
por: Liu, Yu-Sheng, et al.
Publicado: (2011)

Lipoprotein-associated phospholipase A2 and oxidized low-density lipoprotein in young patients with acute coronary syndrome in China
por: Huang, Yuli, et al.
Publicado: (2017)

Association of lipoprotein‐associated phospholipase A2 mass with asymptomatic cerebral artery stenosis
por: Wang, Youxin, et al.
Publicado: (2018)

Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow
por: Ding, Yao-dong, et al.
Publicado: (2020)

An association study between genetic polymorphisms related to lipoprotein-associated phospholipase A(2) and coronary heart disease
por: XU, LIMIN, et al.
Publicado: (2013)

Study on the correlation between the concentration of plasma lipoprotein-associated phospholipase A2 and coronary heart disease
por: Cen, Jin-Ming, et al.
Publicado: (2015)

Alteration in lipoprotein-associated phospholipase A2 levels during acute coronary syndrome and its relationship to standard biomarkers
por: Ostadal, Petr, et al.
Publicado: (2012)

Relationship between the neutrophil to high-density lipoprotein cholesterol ratio and severity of coronary artery disease in patients with stable coronary artery disease
por: Gao, Jie, et al.
Publicado: (2022)

Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease
por: Doody, Rachelle S., et al.
Publicado: (2015)

Association of Lipoprotein-associated Phospholipase A2 with Coronary Calcification among American and Japanese Men
por: El-Saed, Aiman, et al.
Publicado: (2007)

Lipoprotein-Associated Phospholipase A(2) Activity and Incident Coronary Heart Disease Among Men and Women With Type 2 Diabetes
por: Hatoum, Ida J., et al.
Publicado: (2010)

Relationship of Placental and Serum Lipoprotein-Associated Phospholipase A2 Levels with Hypertensive Disorders of Pregnancy
por: Wang, Jing, et al.
Publicado: (2022)

The Prognostic Value of Lipoprotein-Associated Phospholipase A(2) in the Long-Term Care of Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Yang, Lijiao, et al.
Publicado: (2017)

Relationship of lipoprotein-associated phospholipase A2(Lp-PLA2) and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention
por: Yin, Yun-jie, et al.
Publicado: (2020)

Lipoprotein‐associated phospholipase A2: The story continues
por: Huang, Fubao, et al.
Publicado: (2019)

Lipoprotein-Associated Phospholipase A2 Is a Risk Factor for Patients With Parkinson’s Disease
por: Wu, Zubo, et al.
Publicado: (2021)

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies
Publicado: (2010)

Lipoprotein-Associated Phospholipase A2 Activity as Potential Biomarker of Vascular Dementia
por: Zuliani, Giovanni, et al.
Publicado: (2023)

Change in lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndrome
por: Li, Jingwei, et al.
Publicado: (2018)

Lipoprotein‐Associated Phospholipase A(2) Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease
por: Wallentin, Lars, et al.
Publicado: (2016)

Lipoprotein-Associated Phospholipase A(2) Is Related to Plaque Stability and Is a Potential Biomarker for Acute Coronary Syndrome
por: Chung, Hyemoon, et al.
Publicado: (2014)

Lipoprotein-associated phospholipase-A(2) activity and its diagnostic potential in patients with acute coronary syndrome and acute ischemic stroke
por: Kocak, Sedat, et al.
Publicado: (2016)

Association between lipoprotein(a) and peripheral arterial disease in coronary artery bypass grafting patients
por: Yi, Cheng, et al.
Publicado: (2023)

Elevated lipoprotein(a) and lipoprotein-associated phospholipase A(2) are associated with unfavorable functional outcomes in patients with ischemic stroke
por: Jiang, Xue, et al.
Publicado: (2021)

Elevated Lipoprotein-Associated Phospholipase A2 Is Associated With Intracranial Atherosclerosis
por: Wang, Yuan, et al.
Publicado: (2022)

Diabetes status modifies the long-term effect of lipoprotein-associated phospholipase A2 on major coronary events
por: Siddiqui, Moneeza K., et al.
Publicado: (2021)

The Association of Syntax Score with Levels of Lipoprotein(a) and Inflammatory Biomarkers in Patients with Stable Coronary Artery Disease and Different Low-Density Lipoprotein Cholesterol Levels
por: Xu, Weifeng, et al.
Publicado: (2020)

Association Between Plasma Lipoprotein-Associated Phospholipase A2 and Plaque Vulnerability in TIA Patients With Unilateral Middle Cerebral Artery Stenosis
por: Qin, Yiren, et al.
Publicado: (2020)

Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis
por: Zhang, Juan, et al.
Publicado: (2016)

Racial variation in lipoprotein-associated phospholipase A(2 )in older adults
por: Lee, Keane K, et al.
Publicado: (2011)

Active site competition is the mechanism for the inhibition of lipoprotein-associated phospholipase A(2) by detergent micelles or lipoproteins and for the efficacy reduction of darapladib
por: Zhuo, Shaoqiu, et al.
Publicado: (2020)

Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development
por: Wu, Dongmei, et al.
Publicado: (2021)

Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories
por: Dhamoon, Mandip S., et al.
Publicado: (2019)

Elevated serum lipoprotein(a) is significantly associated with angiographic progression of coronary artery disease
por: Shui, Xing, et al.
Publicado: (2021)

Association of Lipoprotein-Associated Phospholipase A2 with the Prevalence of Nonalcoholic Fatty Liver Disease: A Result from the APAC Study
por: Liu, Zhongni, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vbviir0m42nnkeveojlo8e5mds